ProfileGDS5678 / 1443116_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 55% 50% 53% 51% 52% 57% 55% 54% 52% 53% 54% 52% 55% 53% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.4132655
GSM967853U87-EV human glioblastoma xenograft - Control 23.2027150
GSM967854U87-EV human glioblastoma xenograft - Control 33.3028953
GSM967855U87-EV human glioblastoma xenograft - Control 43.1894151
GSM967856U87-EV human glioblastoma xenograft - Control 53.221252
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.5477157
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.4535855
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.3357254
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.2497752
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.2681853
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.3207854
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.2138852
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.3702255
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.3127353